hero

Portfolio Careers

Discover opportunities across our network of portfolio companies.
Vertex Ventures HC
Vertex Ventures HC
22
companies
90
Jobs
Bicycle Therapeutics
Bicycle Therapeutics
bicycletherapeutics.com

Locations

Cambridge, MA, USA · Cambridge, UK

industry

Biotechnology · DeepTech · Health

Size

201-1000 employees

Stage

Other

founded in

2009

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTC™) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICA™ targeting Nectin-4 and agonizing CD137, in company-sponsored Phase I/II trials. In addition, BT1718, a BTC that targets MT1-MMP, is being investigated in an ongoing Phase I/IIa clinical trial sponsored by the Cancer Research UK Centre for Drug Development.

Something looks off?
Open jobs at Bicycle Therapeutics

On-site & Remote